TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Direct costs attributable to producing goods sold
5Y CAGR
-40.8%/yr
Long-term compound
Percentile
P67
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $1.49M | - |
| 2024 | $0.00 | - |
| 2023 | $0.00 | - |
| 2022 | $0.00 | - |
| 2021 | $0.00 | -100.0% |
| 2020 | $20.58M | +117.9% |
| 2019 | $9.44M | - |